Screener
Opus Genetics IRD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Other income, net | 844 | 302 |
| Loss before income taxes | (65,535) | (8,194) |
| Benefit (provision) for income taxes | — | — |
| Net loss | (65,535) | (8,194) |
| Other comprehensive loss, net of tax | — | — |
| Comprehensive loss | $(65,535) | $(8,194) |
| Net loss per share: | ||
| Basic and diluted | $(0.75) | $(0.24) |
Item 1. Financial Statements
FAQ
- What is Opus Genetics's net income?
- Opus Genetics (IRD) reported net income of -$65.54M in Q1 2026.
- How has Opus Genetics's net income changed year-over-year?
- Opus Genetics's net income decreased by 699.8% year-over-year, from -$8.19M to -$65.54M.
- What is the long-term trend for Opus Genetics's net income?
- Over 4 years (2021 to 2025), Opus Genetics's net income has grown at a -3.3% compound annual growth rate (CAGR), from -$56.69M to -$49.59M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Opus Genetics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude